Literature DB >> 18404954

Ocular infections due to anaerobic bacteria in children.

Itzhak Brook1.   

Abstract

The recent increased recovery of anaerobic bacteria from children has led to greater appreciation of the role these organisms play in pediatric infections at all body sites, including the eye. In studies that employed adequate methods for recovery of anaerobes, they were isolated from approximately one-third of the children with conjunctivitis, half of the time in pure culture. The predominant recovered anaerobes were Clostridium spp., gram-negative anaerobic bacilli, and Peptostreptococcus spp. Anaerobic bacteria were also recovered from patients who wore contact lenses and developed conjunctivitis, and were reported in cases of keratitis. The most frequently recovered anaerobes were Propionibacterium spp., Peptostreptococcus spp., Clostridium spp., Prevotella spp., and Fusobacterium spp. The most frequently recovered anaerobes from dacryocystitis were Peptostreptococcus spp., Propionibacterium spp., Prevotella spp., and Fusobacterium spp. This review describes the microbiology, diagnosis, and management of ocular infections due to anaerobic bacteria in children.

Entities:  

Mesh:

Year:  2008        PMID: 18404954     DOI: 10.3928/01913913-20080301-02

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  3 in total

1.  Evaluation of the new OxyPlate™ Anaerobic System for the isolation of ocular anaerobic bacteria.

Authors:  Emily K Deschler; Paul P Thompson; Regis Paul Kowalski
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

2.  Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis.

Authors:  Timothy L Comstock; Paul M Karpecki; Timothy W Morris; Jin-Zhong Zhang
Journal:  Clin Ophthalmol       Date:  2010-04-26

3.  Bacteriological profile and drug susceptibility patterns in dacryocystitis patients attending Gondar University Teaching Hospital, Northwest Ethiopia.

Authors:  Yared Assefa; Feleke Moges; Mengistu Endris; Banchamlak Zereay; Bemnet Amare; Damtew Bekele; Solomon Tesfaye; Andargachew Mulu; Yeshambel Belyhun
Journal:  BMC Ophthalmol       Date:  2015-04-02       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.